Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...

Today, the American Kidney Fund (AKF) is kicking off its seventh annual Kidney Action Week®, the only free, virtual conference in the country that brings together members of the kidney ...

Arcus Biosciences (NYSE:RCUS) reported positive late stage efficacy results for casdatifan, its investigational HIF-2a inhibitor, in late line renal cell carcinoma. The company released biomarker ...

US pharma major Merck (NYSE: MRK) has reported a Phase III success for Welireg (belzutifan) plus Keytruda (pembrolizumab) as ...

High-protein diets are a frequent topic in clinics, sparking concerns about kidney harm for some and perceived benefits for others. The reality is nuanced, with the source and quantity of protein, as ...

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

A new study published in the journal of Communications Medicine showed that infants born to mothers with renal disease are ...

Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste ...

Trichy: As organ donations across Tamil Nadu witness an unprecedented surge in the first two months of this year, Mahatma Gandhi Memorial Government H.

At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...

Infection, comorbidities, renal pathologic features, male sex, and disease activity are risk factors for AKI among patients with LN.

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...